Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02154711 · ClinicalTrials.gov registry record
Magnetic Resonance Imaging (MRI) Muscle Phenotyping in Mitochondrial Disease
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 40
- Enrollment target
NCT02154711: Completed study, sponsored by University of Pennsylvania.
NCT02154711 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02154711 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
The purpose of the study is to use a new research imaging technique, a kind of magnetic resonance imaging (MRI), to measure important metabolic features of muscle, including mitochondrial function, in people with mitochondrial disease and in healthy individuals. (Mitochondria are tiny organelles that generate energy for the body.) It is hoped that this new strategy will help physicians to understand better the health problems of people with mitochondrial disease. Eventually, this could lead to better diagnostic and treatment approaches.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2014-05 |
| Est. Completion | 2020-06-30 |
What the finished NCT02154711 record still lists
NCT02154711 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02154711 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02154711 about?
NCT02154711 is a clinical study titled "Magnetic Resonance Imaging (MRI) Muscle Phenotyping in Mitochondrial Disease". The purpose of the study is to use a new research imaging technique, a kind of magnetic resonance imaging (MRI), to measure important metabolic features of muscle, including mitochondrial function, in people with mitochondrial disease and in healthy individuals. (Mitochondria are tiny organelles tha...
What is the current status of trial NCT02154711?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2014-05. Estimated completion is 2020-06-30.
Who is sponsoring clinical trial NCT02154711?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia